Bystander memory T cells and IMiD/checkpoint therapy in multiple myeloma: A dangerous tango?
Peer reviewed, Journal article
MetadataShow full item record
Original versionFrontiers in Immunology. 2021, 12, 1-7. 10.3389/fimmu.2021.636375
In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy